Clinical Trial Update: Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee Replacement [Phase 3]

View source ↗

Summary

Phase 3 results comparing dabigatran etexilate to enoxaparin for prevention of venous thromboembolism after total knee replacement; results were posted in Decem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Lovenox (enoxaparin)
• Pradaxa (dabigatran etexilate)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Arthroplasty, Replacement, Knee, Thromboembolism | Phase 3 | Status: COMPLETED | Results posted: 2010-12-17